Efficacy and Safety of Switching from Entecavir to Tenofovir Alafenamide for Chronic Hepatitis B Patients with Low-Level Viremia.

Yan D, Zhu SH, Yuan YY, Huang YD, Yang JZ.

Open source

DOI
10.1007/s11596-026-00243-3
Published
2026-09-08
Container
Curr Med Sci
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s11596-026-00243-3,
  title = {Efficacy and Safety of Switching from Entecavir to Tenofovir Alafenamide for Chronic Hepatitis B Patients with Low-Level Viremia.},
  author = {Yan D and  Zhu SH and  Yuan YY and  Huang YD and  Yang JZ.},
  year = {2026},
  journal = {Curr Med Sci},
  doi = {10.1007/s11596-026-00243-3},
  url = {https://doi.org/10.1007/s11596-026-00243-3}
}

RIS

TY  - JOUR
TI  - Efficacy and Safety of Switching from Entecavir to Tenofovir Alafenamide for Chronic Hepatitis B Patients with Low-Level Viremia.
AU  - Yan D
AU  -  Zhu SH
AU  -  Yuan YY
AU  -  Huang YD
AU  -  Yang JZ.
PY  - 2026
JO  - Curr Med Sci
DO  - 10.1007/s11596-026-00243-3
UR  - https://doi.org/10.1007/s11596-026-00243-3
ER  - 

APA

D, Y., SH, Z., YY, Y., YD, H., & JZ., Y. (2026). Efficacy and Safety of Switching from Entecavir to Tenofovir Alafenamide for Chronic Hepatitis B Patients with Low-Level Viremia.. Curr Med Sci. https://doi.org/10.1007/s11596-026-00243-3

Source records